Abstract
Two new organopolyphosphazenes, viz., poly[bis(3-methoxy benzyloxy) phosphazene] (POP-1) and poly[bis(4-fluoro-4′-oxybenzophenone)]phosphazene (POP-2), have been prepared by replacing chlorine atoms of dichloropolyphosphazene with 3-methoxy benzylalcohol and 4-fluoro-4′-hydroxy-benzophenone. The polymers have been characterized by Fourier tranform infrared spectroscopy (FT-IR), 1H- and 31P-nuclear magnetic resonance (NMR) spectra and thermogravimetric (TGA) analyses. The polymers have been developed as microspheres to study their controlled-release characteristics for indomethacin, an anti-inflammatory drug. Drug-loaded microspheres have been tested for in vitro release in pH 7.4 buffer media. FT-IR, 1H- and 31P-NMR data confirmed the formation of polyorganophosphazenes substituted with 3-methoxy benzylalcohol and 4-fluoro-4′-hydroxy-benzophenone. In vitro drug-release studies have indicated sustained and controlled release of indomethacin through POP microspheres.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
